Summary
Introduction
The antihypertensive effects of the 8-adrenoreceptor blockers have been well documented in many races but in at least one racial group, the negroes, there is some uncertainty as to the effectiveness of these drugs. The initial studies Jamaicans suggested that propranolol was ineffective as an antihypertensive agent in that population. This conclusion was also arrived at by Richardson, Freund, Gear, Mauck & Preston (1968) in a study amongst American blacks and by Seedat & Reddy (1971) in South African Bantus. In a group of West Africans, Falase, Salako 8z Aderounmu (1977) found the antihypertensive effect of pindolol to be less than was usually reported for other races. The present study was undertaken in order to determine the acute effects of propranolol and pindolol on blood pressure and pulse rate at rest and after exercise and relate these to the blood concentrations of the drugs in a group of hypertensive Africans, and to provide simple pharmacokinetic data on the drugs as well as information on their /?-adrenoreceptor-blocking activity.
Materials and methods
Studies were carried out on nine hypertensive patients, all Africans, who had been receiving treatment for more than 2 years. They had all been previously investigated and a diagnosis of essential hypertension made. None of the patients was in heart failure and none had hepatic, renal or cerebral complications. Only patients with pretreatment diastolic blood pressures between 95 and 120 mmHg were chosen. Their ages ranged between 32 and 50 years (mean 40.9 & SE 2.1).
After selection of patients for the study, all antihypertensive drugs were withdrawn for 4 weeks. The subsequent design of the study was a doubleblind within-patient cross-over comparison of pindolol (20 me), propranolol (100 mg) and placebo, the drugs being administered in a random order with an interval of 2 weeks between two treatments. The studies were performed in the 393s 394s L. A. Salako, A. 0. Falase and A . Fadeke Aderounmu morning starting 2 h after a light breakfast. The patients were allowed to rest on a couch for 30 min before commencing the experimental measurements. At the beginning of the study, heart rate and blood pressure were measured at rest and after exercise and 10 ml of venous blood was withdrawn from an antecubital vein. The patient then took the drug with 150 ml of water. The heart rate and blood pressure measurements at rest and after exercise and venepuncture were repeated 4, 1, 2, 4 and 6 h after administration of the drug. The exercise consisted of stepping up and down a 1 ft high stool at the rate of one per second for 1 min. Blood was taken into a lithium/heparin bottle and centrifuged immediately to separate the plasma, which was then stored frozen at -20°C until analysed.
The values obtained for heart rate and blood pressure after each treatment were expressed as changes from the pretreatment values and the mean changes after propranolol and pindolol were than compared with the mean changes after the placebo by using Student's t-test.
Propranolol was estimated in plasma by the fluorimetric method of Shand, Nuckolls & Oats (1970) and pindolol by the method of Pacha Table; probability values less than 5% are regarded as significant.
Results
The mean heart rate, systolic and diastolic blood pressure at rest and after exercise before and at intervals after administration of placebo, pindolol and propranolol, are shown in Table 1 . There was no significant difference between the heart rates before the three treatments. After each of the three drugs there was a reduction in both the resting and the exercise heart rates. The significance of the pindolol-and propranolol-induced reduction in heart rate was estimated by comparing the reduction after pindolol and propranolol with that after placebo at the various time intervals. This analysis shows that both at rest and after exercise propranolol produced a significant reduction in heart rate beginning 1 h after administering the drug and persisting for the rest of the 6 h study period. Pindolol, on the other hand, had no significant effect on the resting heart rate but significantly lowered the exercise heart rate. This effect started 30 min after giving the drug and continued for the 6 h observation period.
Pindolol significantly reduced systolic blood pressure at rest and after exercise, the effect starting at 1 h and continuing for 6 h. Propranolol similarly reduced systolic blood pressure after exercise. At rest, a significantly reduced systolic blood pressure was produced only at the 2 h interval after taking propranolol. There was no significant change in diastolic blood pressure by either drug both at rest and after exercise. There was similarly no significant difference between the effects of pindolol and propranolol with respect ot all the three parameters measured at rest and after exercise.
The Table also shows the mean values of plasma pindolol and propranolol concentrations at the various time intervals. With both drugs, the mean plasma concentration rose rapidly, reaching a maximum at 2 h and thereafter falling gradually until the sixth hour. The drug plasma concentrations thus appeared to parallel the druginduced changes in heart rate and systolic blood pressure. Indeed, a plot of the time course of plasma concentrations and p-adrenoreceptorblocking activity (expressed as percentage inhibition of post-exercise tachycardia) for both pindolol and propranolol showed that the two parameters followed a similar course, with peak plasma concentrations and peak biological activity occurring 2 h after administration of the drugs.
Discussion
The results of this study show that pindolol produced a significant reduction in systolic blood pressure at rest and after exercise and lowered heart rate after exercise but not at rest. Propranolol caused a significant reduction in the exercise systolic blood pressure and in the resting and exercise heart rates. Pindolol has intrinsic sympathomimetic activity and has even been found in some studies to cause an increase in resting heart rate (Oh, Kaye, Warrington, Taylor & Wadsworth, 1978) when there has been no sympathetic influence on the heart. Its failure to reduce resting heart rate significantly in this study is therefore consistent with its pharmacological properties. On the other hand, propranolol, which has no intrinsic sympathomimetic activity, is well known to lower the heart rate at rest (McDevitt, 1977) . Our results in African subjects are therefore in agreement with what is known about the effects of these drugs in other races.
During exercise, the parasympathetic tone on the heart is reduced and the heart then comes predominantly under sympathetic control (Robinson, Epstein, Beiser & Braunwald, 1966) . A reduction in exercise heart rate can then be used as an index of padrenoreceptor blockade. The reduction in exercise heart rate by pindolol and propranolol in this study confirms their p-adrenoreceptor-blocking activity in the subjects studied. To a lesser extent, systolic blood pressure is also determined by preceptor sympathetic activity and its reduction in the subjects studied is also a manifestation of the acute &idrenoreceptor-blocking effects of pindolol and propranolol. The lack of effect of the single doses of the drugs on diastolic blood pressure in these subjects is compatible with the well-known observation that the clinically useful antihypertensive effect of @-adrenoreceptor-blocking drugs is a chronic rather than an acute effect (Prichard, 1978) .
The plasma concentration of pindolol reached approximately one-third of its peak concentrations in 30 min. The mean concentration of propranolol at 30 min relative to its mean peak concentration was less than one third, but the peak of the mean concentrations for both drugs occurred at the same time: 2 h. The time to peak concentration in individual patients varied from 1 to 4 h with pindolol, and from 2 to 4 h with propranolol (mean values 2.3 0.33 for pindolol.and 2.9 f 0.35 for propranolol). These values are in good agreement with data from the literature (Johnsson & Regardh, 1976) .
In view of these results it is difficult to implicate simple pharmacodynamic or pharmacokinetic mechanisms in the apparently poor response of black racial groups to the antihypertensive effects of these drugs.
